MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

Por Pourhassan, H, DeFor, T, Trottier, B, Dolan, M, Brunstein, C, Bejanyan, N, Ustun, C, Warlick, E D
Publicado no Bone Marrow Transplant (2016)

The Impact of Delayed Infusion Time in Umbilical Cord Blood Transplantation

Por Mitchell, R., Wagner, J. E., Brunstein, C., Cao, Q., McKenna, D. H., Verneris, M. R.
Publicado no Biol Blood Marrow Transplant (2017)

Impact of long term cryopreservation on single umbilical cord blood transplant outcomes

Por Mitchell, R., Wagner, J.E., Brunstein, C.G., Cao, Q., McKenna, D.H., Lund, T.C., Verneris, M.R.
Publicado no Biol Blood Marrow Transplant (2014)

Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation

Por Jacobson, P, El-Massah, SF, Rogosheske, J, Kerr, A, Long-Boyle, J, DeFor, T, Jennissen, C, Brunstein, C, Wagner, J, Tomblyn, M, Weisdorf, D
Publicado em 2009